Table 1. Dermographic features.
Age (years) | 47.16 ± 13.14a |
Sex, n (%) | Man: 101 (75.4) |
Woman: 33 (24.6) | |
With psoriatic arthritis, n (%) | 42 (32.1) |
Mean follow-up months | 20.5 ± 10.52a |
Previous biological treatment, n (%) | Etanercept: 24 (17.9) |
Adalimumab: 23 (17.2) | |
Combined treatment, n (%) | Methotrexate: 12 (9) |
Etanercept: 4 (3) | |
Adalimumab: 1(0.7) |
aStandard deviation